International Symposium at the Vatican on Hansen’s Disease To Focus on Theme of “Leave No One Behind”
TOKYO, Jan. 20, 2023 /PRNewswire/ -- French Raoul Follereau Fondation, Italian Association Amici di Raoul Follereau and Sasakawa Leprosy (Hansen's Disease) Initiative, in collaboration with the Dicastery for Promoting Integral Human Development, will co-host the "International Symposium at the Vatican on Hansen's Disease: Leave No One Behind" on January 23-24, 2023 at Auditorium "P. Agostino Trape", Patristic Institute Augustinianum....
Revitalize Beauty Through Science: Skincare Tech Brand AMIRO Unveils Its All-In-One LED Light Therapy Face Mask
SHENZHEN, China, Jan. 20, 2023 /PRNewswire/ -- Tech-centric beauty brand AMIRO has just unveiled its latest skincare device, the AMIRO L1 LED Light Therapy Face Mask, as a response to consumer demand. AMIRO L1 LED Light Therapy Face Mask The anti-aging LED face mask is built to emit four wavelengths of light for...
SK bioscience Appoints New Executives to Accelerate New Growth Strategies
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies With recruitment of global talent and capabilities accumulated during the COVID-19 pandemic, SK bioscience will continue to achieve sustainable growth SEOUL, South Korea, Jan. 20, 2023 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to...
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties
COVID-19 Prevention and Treatment Live-Streaming Training for Rural Doctors Attracted over 1 Million Views HONG KONG, Jan. 20, 2023 /PRNewswire/ -- On January 16, the second stage of "A Healthy Winter Action" initiated by Fosun Foundation in conjunction with other institutions kicked off, with 19,600 bottles of Azvudine gradually shipped to the rural clinics of 24 counties across Sichuan,...
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression
PRINCETON, N.J., SHANGHAI and SUZHOU, China, Jan. 20, 2023 /PRNewswire/ -- Duality Biologics ("DualityBio"), a clinical-stage biotech company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to DB-1303 for...
CNN’s ‘Vital Signs’ explores the potential of medical non-invasive therapeutic technology
HONG KONG, Jan. 20, 2023 /PRNewswire/ -- As the search continues for non-invasive ways to treat neurodegenerative diseases, focused ultrasounds have become an alternative to surgery when it comes to treating essential and Parkinson's tremors. This month on CNN's 'Vital Signs', CNN's Chief Medical Correspondent Dr. Sanjay Gupta speaks to the experts working on this non-invasive therapeutic technology and explores how this...
Global Times: Spring Festival hustle and bustle back, heralds vibrant year ahead
BEIJING, Jan. 20, 2023 /PRNewswire/ -- The Spring Festival of 2023 is destined to be unique, as it will be a year of return, of remembrance and letting go, of a new start to a more vibrant future after the country has optimized its COVID-19 responses, gradually walking out of the cloud of the epidemic. After COVID-19 disrupted the plan...
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS
TORONTO, Canada and BEIJING, Jan. 20, 2023 /PRNewswire/ -- BriSTAR Immunotech, a clinical-stage cell therapy company, announced today it will showcase its T-cell receptors (TCR) and antigen receptor (STAR)-T cell therapy technology platform at the American Association for Cancer Research (AACR) special conference on acute myeloid leukemia and myelodysplastic syndrome, taking place January 23-25, 2023, in Austin, Texas. "The...
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases
SAN DIEGO, Jan. 20, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced its wholly-owned subsidiary Mabwell Therapeutics has entered into an agreement with DISC MEDICINE, INC. ("Disc") about 9MW3011 (R&D code in the US: MWTX-001, MWTX-002 & MWTX-003). Under the terms of the agreement, Disc will obtain exclusive rights to...
VISTA Eye Specialist to host Eye Health Carnival Nationwide in Malaysia
PETALING JAYA, Malaysia, Jan. 20, 2023 /PRNewswire/ -- In an effort to increase eye health awareness for Malaysians, particularly on the top 3 causes of preventable blindness, VISTA Eye Specialist is excited to announce the return of their Eye Health Carnival nationwide, happening mid-February, 2023 at 12 of its centers across Malaysia. Themed "Happy TuGather", this year's carnival is...
